Phase II Study of Concurrent Radiation Therapy, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus as First-Line Treatment for Patients With Glioblastoma.
| Autor: | Hainsworth, John D., Shih, Kent C., Shepard, Gregg C., Tillinghast, Guy W., Brinker, Brett T., Spigel, David R. |
|---|---|
| Zdroj: | Clinical Advances in Hematology & Oncology; Apr2012, Vol. 10 Issue 4, p240-246, 7p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|